ID

38210

Descripción

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry; ODM derived from: https://clinicaltrials.gov/show/NCT02302742

Link

https://clinicaltrials.gov/show/NCT02302742

Palabras clave

  1. 27/9/19 27/9/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

27 de septiembre de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT02302742

Eligibility Breast Cancer NCT02302742

Criteria
Descripción

Criteria

triple negative breast cancer
Descripción

Triple Negative Breast Neoplasms

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3539878
er/pr <10% and her negative per current asco/cap guidelines
Descripción

Estrogen Receptors Percentage | Progesterone Receptors Percentage | Human epidermal growth factor receptor negative

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0034804
UMLS CUI [1,2]
C0439165
UMLS CUI [2,1]
C0034833
UMLS CUI [2,2]
C0439165
UMLS CUI [3]
C4087185
stages i-iv
Descripción

TNM Breast tumor staging

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0474926
any age at diagnosis
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
patient must be within 5 years of diagnosis
Descripción

Diagnosis Timespan

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011900
UMLS CUI [1,2]
C0872291
eligible regardless of genetic testing status
Descripción

Patient eligible for clinical trial Independent of Genetic testing

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1302261
UMLS CUI [1,2]
C0332291
UMLS CUI [1,3]
C0679560
genetic testing recommended for patients meeting nccn and medicare guidelines
Descripción

Genetic testing Recommended

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0679560
UMLS CUI [1,2]
C0034866
and/or
Descripción

ID.8

Tipo de datos

boolean

germline mutation carriers
Descripción

Germ-Line Mutation Carrier

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0206530
UMLS CUI [1,2]
C2985478
patients with deleterious or uncertain mutations in hboc genes (brca, pten, p53,-palb2 etc) are eligible regardless of type/site of cancer
Descripción

HBOC Genes | BRCA gene | PTEN gene | TP53 gene | PALB2 gene | Patient eligible for clinical trial Independent of Cancer site

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0677776
UMLS CUI [1,2]
C0017337
UMLS CUI [2]
C0596223
UMLS CUI [3]
C0694888
UMLS CUI [4]
C0079419
UMLS CUI [5]
C1835898
UMLS CUI [6,1]
C1302261
UMLS CUI [6,2]
C0332291
UMLS CUI [6,3]
C0872338
healthy patients harboring mutations also eligible
Descripción

Healthy Volunteers Mutation | Patient eligible for clinical trial

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1708335
UMLS CUI [1,2]
C0026882
UMLS CUI [2]
C1302261
there is no time limit from the time of diagnosis of cancer and enrollment.
Descripción

Time limit Absent | Cancer diagnosis | Enrollment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332186
UMLS CUI [1,2]
C0332197
UMLS CUI [2]
C0920688
UMLS CUI [3]
C1516879
eligible regardless of personal history of cancer
Descripción

Patient eligible for clinical trial Independent of Cancer History

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1302261
UMLS CUI [1,2]
C0332291
UMLS CUI [1,3]
C1512706
exclusion criteria include:
Descripción

Exclusion Criteria

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
triple negative breast cancer -patient is not within five years of diagnosis
Descripción

Triple Negative Breast Neoplasm Previous

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3539878
UMLS CUI [1,2]
C0205156
germline mutation carriers:
Descripción

Germ-Line Mutation Carrier

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0206530
UMLS CUI [1,2]
C2985478
patient only carries a hboc mutation that is classified as "polymorphism" of "favor polymorphism"
Descripción

HBOC Mutation Singular | Polymorphism

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0677776
UMLS CUI [1,2]
C0026882
UMLS CUI [1,3]
C0205171
UMLS CUI [2]
C1882417

Similar models

Eligibility Breast Cancer NCT02302742

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Triple Negative Breast Neoplasms
Item
triple negative breast cancer
boolean
C3539878 (UMLS CUI [1])
Estrogen Receptors Percentage | Progesterone Receptors Percentage | Human epidermal growth factor receptor negative
Item
er/pr <10% and her negative per current asco/cap guidelines
boolean
C0034804 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0034833 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C4087185 (UMLS CUI [3])
TNM Breast tumor staging
Item
stages i-iv
boolean
C0474926 (UMLS CUI [1])
Age
Item
any age at diagnosis
boolean
C0001779 (UMLS CUI [1])
Diagnosis Timespan
Item
patient must be within 5 years of diagnosis
boolean
C0011900 (UMLS CUI [1,1])
C0872291 (UMLS CUI [1,2])
Patient eligible for clinical trial Independent of Genetic testing
Item
eligible regardless of genetic testing status
boolean
C1302261 (UMLS CUI [1,1])
C0332291 (UMLS CUI [1,2])
C0679560 (UMLS CUI [1,3])
Genetic testing Recommended
Item
genetic testing recommended for patients meeting nccn and medicare guidelines
boolean
C0679560 (UMLS CUI [1,1])
C0034866 (UMLS CUI [1,2])
ID.8
Item
and/or
boolean
Germ-Line Mutation Carrier
Item
germline mutation carriers
boolean
C0206530 (UMLS CUI [1,1])
C2985478 (UMLS CUI [1,2])
HBOC Genes | BRCA gene | PTEN gene | TP53 gene | PALB2 gene | Patient eligible for clinical trial Independent of Cancer site
Item
patients with deleterious or uncertain mutations in hboc genes (brca, pten, p53,-palb2 etc) are eligible regardless of type/site of cancer
boolean
C0677776 (UMLS CUI [1,1])
C0017337 (UMLS CUI [1,2])
C0596223 (UMLS CUI [2])
C0694888 (UMLS CUI [3])
C0079419 (UMLS CUI [4])
C1835898 (UMLS CUI [5])
C1302261 (UMLS CUI [6,1])
C0332291 (UMLS CUI [6,2])
C0872338 (UMLS CUI [6,3])
Healthy Volunteers Mutation | Patient eligible for clinical trial
Item
healthy patients harboring mutations also eligible
boolean
C1708335 (UMLS CUI [1,1])
C0026882 (UMLS CUI [1,2])
C1302261 (UMLS CUI [2])
Time limit Absent | Cancer diagnosis | Enrollment
Item
there is no time limit from the time of diagnosis of cancer and enrollment.
boolean
C0332186 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0920688 (UMLS CUI [2])
C1516879 (UMLS CUI [3])
Patient eligible for clinical trial Independent of Cancer History
Item
eligible regardless of personal history of cancer
boolean
C1302261 (UMLS CUI [1,1])
C0332291 (UMLS CUI [1,2])
C1512706 (UMLS CUI [1,3])
Exclusion Criteria
Item
exclusion criteria include:
boolean
C0680251 (UMLS CUI [1])
Triple Negative Breast Neoplasm Previous
Item
triple negative breast cancer -patient is not within five years of diagnosis
boolean
C3539878 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Germ-Line Mutation Carrier
Item
germline mutation carriers:
boolean
C0206530 (UMLS CUI [1,1])
C2985478 (UMLS CUI [1,2])
HBOC Mutation Singular | Polymorphism
Item
patient only carries a hboc mutation that is classified as "polymorphism" of "favor polymorphism"
boolean
C0677776 (UMLS CUI [1,1])
C0026882 (UMLS CUI [1,2])
C0205171 (UMLS CUI [1,3])
C1882417 (UMLS CUI [2])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial